HIV-RNA VIRAL LOAD REDUCTION OF .5 LOG IS PREDICTIVE OF CLINICAL BENEFIT -- FDA ADVISORY CMTE.; FUTURE OF HIV TREATMENT IS INDIVIDUALIZING THERAPY -- FDA's FEIGAL
Executive Summary
A .5 log reduction in HIV-RNA viral load is an acceptable indicator of virologic response in clinical trials of experimental HIV drugs, FDA's Antiviral Drugs Advisory Committee agreed at its July 14-15 meeting.